2025 Annual Shareholders’ Meeting and Director Nominations
FOR PUBLIC RELEASE
NZX Limited
Wellington
15 August 2025
2025 Annual Shareholders’ Meeting and Director Nominations
Annual Meeting
Rua Bioscience Limited (NZX: RUA) advises that its 2025 Annual Shareholders’ Meeting will be held at 3:00pm
(New Zealand time) on Tuesday, 28 October 2025. The meeting will be held virtually via Computershare’s online
meeting platform. Further details for participation and voting online will be included in the formal Notice of
Annual Shareholders’ Meeting which will be released prior to the meeting.
Following the Annual Shareholders Meeting there will be an investor meeting held in Ruatorea where many
shareholders reside, which will provide an opportunity to meet and interact with the Board and management.
Director Nominations
The Board currently has four Directors, one of whom is standing for re-election at the upcoming Annual
Shareholders Meeting.
Rua advises that for the purposes of NZX listing rule 2.3.2 the closing date for Director nominations is 5:00pm
NZST on Friday 12
th
September 2025.
Any director nomination must be accompanied by the consent in writing of the person nominated and must be
made by a security holder entitled to attend and vote at the meeting. Any nominations should be emailed to:
paul.naske@ruabio.com or addressed to Paul Naske, Chief Executive Officer, Rua Bioscience Limited, PO Box
1387, Gisborne, 4040.
For more information about Rua Bioscience please visit www.ruabio.com.
The person who authorised this announcement:
Paul Naske,
Chief Executive Officer
For shareholder enquiries please visit www.ruabio.com or contact:
info@ruabio.com or 0800 RUABIO
PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com
MARKET ANNOUNCEMENT
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.